Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Upadacitinib may cause hair loss.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Axitinib treatment turned a man's grey hair back to black.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

The combination therapy was effective and well-tolerated, especially in young patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Abatacept may help some people with alopecia areata regrow hair.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Erlotinib can cause hair loss and texture changes.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

The compound 4c showed strong potential as an anticancer agent.

Tofacitinib taken by mouth helps treat hair loss in children.

Talquetamab may cause hair loss and skin issues.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.